author-photo

D Sisco

Université catholique de Louvain

3

Papers

31

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.

2006 The Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (22)
Pharmacokinetics and pharmacodynamics of infliximab, an anti‐tumor necrosis factor‐alpha monoclonal antibody, following single subcutaneous administrations in rheumatoid arthritis patients

2005 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (9)
A phase I study comparing the safety, pharmacokinetics, and pharmacodynamics of infliximab administered by the subcutaneous, intravenous followed by subcutaneous, or intramuscular routes of administration in rheumatoid arthritis patients.

2004 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (0)